KUVA (khellin plus ultraviolet A) stimulates proliferation and melanogenesis in normal human melanocytes and melanoma cells in vitro

British Journal of Dermatology

Volumn 149, Issue 4, 2003, Pages 707-717

  Carlie, G ^a   Ntusi, N B A ^a   Hulley, P A ^b   Kidson, S H ^a  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b UNIVERSITY OF STELLENBOSCH   (South Africa)

Author keywords

Khellin; Khellin plus ultraviolet A; Melanocytes; Melanogenesis; Proliferation; Vitiligo

Indexed keywords

FLUOROCHROME; KHELLIN;

ARTICLE; CELL COUNT; CELL PROLIFERATION; CONTROLLED STUDY; CYTOTOXICITY; DRUG EFFECT; DRUG MECHANISM; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME GLYCOSYLATION; FIBROBLAST; GENE EXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; KUVA; MELANOCYTE; MELANOGENESIS; MELANOMA CELL; MELANOMA MEL 1 CELL; NORTHERN BLOTTING; PHOTOCHEMOTHERAPY; PRIORITY JOURNAL; PROTEIN SYNTHESIS; RADIOMETRY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SOLAR RADIATION; ULTRAVIOLET A RADIATION; VITILIGO; WESTERN BLOTTING;

BLOTTING, NORTHERN; BLOTTING, WESTERN; CELL DIVISION; CELL LINE, TUMOR; CELLS, CULTURED; FIBROBLASTS; HUMANS; KHELLIN; MELANINS; MELANOCYTES; MELANOMA; SKIN NEOPLASMS; ULTRAVIOLET RAYS;

EID: 0242467362     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2133.2003.05577.x     Document Type: Article

References (30)

1. Schwartz RA, Janniger CK. Vitiligo. Cutis 1997; 60: 239-44.
2. Kovacs SO. Vitiligo (review). J Am Acad Dermatol 1998; 38: 647-66.
3. Morliere P, Honigsmann H, Averbeck D et al. Phototherapeutic, photobiological, and photosensitizing properties of khellin. J Invest Dermatol 1988; 90: 720-4.
4. Abdel-Fattah A, Abdoul-Enein MN, Wassel GM, El-Menshawi BS. An approach to the treatment of vitiligo by khellin. Dermatologica 1982; 165: 136-40.
5. Ortel B, Tanew A, Honigsmann H. Khellin UVA phototherapy of vitiligo. Photochem Photobiol 1984; 39: 52S.
6. Honigsmann H, Ortel B. Khellin photochemotherapy of vitiligo. Photodermatology 1985; 2: 193-4.
7. Ortel B, Tanew A, Honigsmann H. Treatment of vitiligo with khellin and ultraviolet A. J Am Acad Dermatol 1988; 18: 693-701.
8. Hofer A, Kerl H, Wolf P. Long-term results in the treatment of vitiligo with oral khellin plus UVA. Eur J Dermatol 2001; 11: 225-9.
9. Vedaldi D, Caffieri S, Dall'Acqua F et al. Khellin, a naturally occurring furochromone, used for the photochemotherapy of skin diseases: mechanisms in action. Farmaco [Sci] 1988; 43: 333-46.
10. Riccio ML, Coratza G, Bovalini L, Martelli P. Investigation of the mutagenic activity in Salmonella typhimurium of the furochromone khellin, proposed as a therapeutic agent for skin diseases. Mutat Res 1992; 279: 103-8.
11. Nordlund JJ, Halder RM, Grimes P. Management of vitiligo. Dermatol Ther 1993; 11: 27-33.
12. Orecchia G, Perfetti L. Photochemotherapy with topical khellin and sunlight in vitiligo. Dermatology 1992; 184: 120-3.
13. Orecchia G, Sangalli ME, Gazzaniga A, Giordano F. Topical photochemotherapy of vitiligo with new khellin formulation: preliminary clinical results. J Dermatol Treat 1998; 9: 65-9.
14. Hoal EG. An experimental study of the human melanoma cells cultured in vitro. PhD Thesis, University of Cape Town 1981.
15. Halaban R, Alfano FD. Selective elimination of fibroblasts from cultures of normal human melanocytes. In Vitro 1984; 20: 447-50.
16. Eisinger M, Marko O. Selective proliferation of normal human melanocytes in vitro in the presence of phorbol ester and cholera toxin. Proc Natl Acad Sci USA 1982; 79: 2018-22.
17. Zsebo KM, Wypych J, McNiece IK et al. Identification, purification, and biological characterisation of hematopoietic stem cell factor from buffalo rat liver-conditioned medium. Cell 1990; 63: 195-201.
18. Kao CH, Yu HS. Comparison of the effect of 8-methoxypsoralen (8-MOP) plus UVA (PUVA) on human melanocytes in vitiligo vulgaris and in vitro. J Invest Dermatol 1992; 98: 734-40.
19. Hearing VJ, Ekel TM. Mammalian tyrosinase. A comparison of tyrosine hydroxylation and melanin formation. Biochemistry 1976; 157: 549-57.
20. Davis LG, Dibner MD, Battey JF. Basic Methods in Molecular Biology. New York: Elsevier, 1986.
21. Donlon TA, Lalande M, Wyman A et al. Isolation of molecular probes associated with the chromosome 15 instability in the Prader-Willi. Proc Natl Acad Sci USA 1986; 83: 4408-12.
22. Bouchard B, Vijayasaradhi S, Houghton AN. Production and characterization of antibodies against human tyrosinase. J Invest Dermatol 1994; 102: 291-5.
23. Marconi B, Mancini F, Colombo P et al. Distribution of khellin in excised human skin following iontophoresis and passive dermal transport. J Control Release 1999; 60: 261-8.
24. Nishimura EK, Jordan SA, Oshima H et al. Dominant role of the niche in melanocyte stem-cell fate determination. Nature 2002; 416: 854-60.
25. Mengeaud V, Ortonne JP. PUVA (5-methoxypsoralen plus UVA) enhances melanogenesis and modulates expression of melanogenic proteins in cultured melanocytes. J Invest Dermatol 1996; 107: 57-62.
26. Luftl M, Rocken M, Plewig G, Degitz K. PUVA inhibits DNA replication, but not gene transcription at nonlethal dosages. J Invest Dermatol 1998; 111: 399-405.
27. Memoli S, Napolitano A, d'Ischia M et al. Diffusible melanin-related metabolites are potent inhibitors of lipid peroxidation. Biochim Biophys Acta 1997; 1346: 61-8.
28. Prota G. Pigment cell research: what directions? (Review). Pigment Cell Res 1997; 10: 5-11.
29. Applegate LA, Frenk E. Cellular defence mechanisms of the skin against oxidant stress and in particular UVA radiation. Eur J Dermatol 1995; 5: 97-103.
30. Vallat VP, Gilleaudeau P, Battat L et al. PUVA bath therapy strongly suppresses immunological and epidermal activation in psoriasis: a possible cellular basis for remittive therapy. J Exp Med 1994; 180: 283-96.